Mammographic and clinical characteristics of different phenotypes of screen-detected and interval breast cancers in a nationwide screening program

被引:0
作者
Marisa Baré
Núria Torà
Dolores Salas
Melchor Sentís
Joana Ferrer
Josefa Ibáñez
Raquel Zubizarreta
Garbiñe Sarriugarte
Teresa Barata
Laia Domingo
Xavier Castells
Maria Sala
机构
[1] UDIAT-DC,Clinical Epidemiology and Cancer Screening
[2] Corporació Sanitària Parc Taulí,Department of Pediatrics, Obstetrics and Gynecology, and Preventive Medicine and Public Health, Faculty of Medicine
[3] Autonomous University of Barcelona (UAB),General Directorate Public Health and Centre for Public Health Research (CSISP)
[4] Research Network on Health Services in Chronic Diseases (REDISSEC),Breast Imaging, Department of Radiology
[5] FISABIO,Department of Radiology
[6] UDIAT-DC,Galician Breast Cancer Screening Programme
[7] Parc Taulí Sabadell,Osakidetza Breast Cancer Screening Programme
[8] Hospital de Santa Caterina,General Directorate of Health Care Programmes
[9] Directorate for Innovation and Management of Public Health,Department of Epidemiology and Evaluation
[10] Basque Country Health Service,undefined
[11] Canary Islands Health Service,undefined
[12] IMIM (Hospital del Mar Medical Research Institute),undefined
来源
Breast Cancer Research and Treatment | 2015年 / 154卷
关键词
Breast cancer; HER2+; Triple-negative; Mammographic features; Screening; Interval cancer;
D O I
暂无
中图分类号
学科分类号
摘要
In the context of a population-based screening program, we aimed to evaluate the major mammographic features and clinicopathological characteristics of breast tumors at diagnosis and the associations between them, focusing on tumors with the worst prognosis. We analyzed cancers diagnosed in a cohort of 645,764 women aged 45–69 years participating in seven population-based screening programs in Spain, between January 1, 2000 and December 31, 2006 and followed up until June 2009. We included all interval cancers and a sample of screen-detected cancers, whether invasive or in situ. We compared tumor-related information and breast density for different phenotypes (Triple-negative (TN), HER2+, Luminal B and Luminal A) in screen-detected and interval cancers. We used Chi-square or Fisher’s exact test to compare major mammographic features of invasive versus in situ tumors, of screen-detected versus interval cancers, and of different types of interval cancers. We included 2582 tumors (1570 screen-detected and 1012 interval cancers). There were significant differences in the distribution of most clinicopathological variables between screen-detected and interval cancers. Invasive TN interval tumors were more common than other phenotypes in breasts with low mammographic density; three-quarters of these tumors presented as masses without associated calcifications. HER2+ tumors were more common in denser breasts and were associated with calcifications and multifocality. Architectural distortion was more common in Luminal A and Luminal B tumors. Certain radiologic findings are associated with pre-invasive lesions; these differ among invasive tumor phenotypes. We corroborate that TN and HER2+ cancers have distinctive appearances also in the context of population-based screening programs. This information can be useful for establishing protocols for diagnostic strategies in screening units.
引用
收藏
页码:403 / 415
页数:12
相关论文
共 219 条
[1]  
Tabar L(2004)Mammographic tumor features can predict long-term outcomes reliably in women with 1–14-mm invasive breast carcinoma Cancer 101 1745-1759
[2]  
Tony Chen HH(2015)Do mammographic tumor features in breast cancer relate to breast density and invasiveness, tumor size, and axillary lymph node involvement? Acta Radiol 56 536-544
[3]  
Amy Yen MF(2012)Molecular biology in breast cancer: intrinsic subtypes and signaling pathways Cancer Treat Rev 38 698-707
[4]  
Tot T(2014)Imaging features of HER2 overexpression in breast cancer: a systematic review and meta-analysis Cancer Epidemiol Biomark Prev 23 1464-1483
[5]  
Tung TH(2014)Association between mammographic features and clinicopathological characteristics in invasive ductal carcinoma of breast cancer Mol Clin Oncol 2 623-629
[6]  
Chen LS(2014)Mammographic and clinicopathological features of triple-negative breast cancer Br J Radiol 87 20130496-464
[7]  
Chiu YH(2012)Triple receptor-negative breast cancer: imaging and clinical characteristics AJR Am J Roentgenol 199 458-1117
[8]  
Duffy SW(2010)Triple-negative breast cancer: correlation between imaging and pathological findings Eur Radiol 20 1111-375
[9]  
Smith RA(2008)Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression Radiology 246 367-410
[10]  
Sartor H(2008)Mammographic features of triple receptor-negative primary breast cancers in young premenopausal women Breast Cancer Res Treat 111 405-675